Skip to main navigation Skip to search Skip to main content

PTEN expression, not mutation status in TSC1, TSC2, or mTOR, correlates with the outcome on everolimus in patients with renal cell carcinoma treated on the randomized RECORD-3 trial

  • Martin H. Voss
  • , David Chen
  • , Albert Reising
  • , Mahtab Marker
  • , Jiayuan Shi
  • , Jianning Xu
  • , Irina Ostrovnaya
  • , Venkatraman E. Seshan
  • , Almedina Redzematovic
  • , Ying Bei Chen
  • , Parul Patel
  • , Xia Han
  • , James J. Hsieh
  • , A. Ari Hakimi
  • , Robert J. Motzer

Research output: Contribution to journal › Article › peer-review

33   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'PTEN expression, not mutation status in TSC1, TSC2, or mTOR, correlates with the outcome on everolimus in patients with renal cell carcinoma treated on the randomized RECORD-3 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science